At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- a Web-Based Platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders (behavioural)
- How long the study runs
- Study runs about 24 months (dates as stated)
- About the drug or intervention
- a Web-Based Platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders — behavioural: The Cognishine platform is a digital (web-based) general health and wellness monitoring platform.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 80
- Started
- 2024-07-03
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for cognitive impairment
- • NA - 80 participants
- • The goal of this feasibility study is to explore rehabilitation outcomes, usability and user experience of a web-based platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders in critical illness and stroke disorders
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with cognitive impairment
Where?
- • Liverpool - Liverpool University Hospitals NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this feasibility study is to explore rehabilitation outcomes, usability and user experience of a web-based platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders in critical illness and stroke disorders. The main question it aims to answer is: " Is it feasible to use a web-based platform for delivering rehabilitation treatment in a large acute National Health Care Organisation" Participants will undergo therapy sessions prescribed by therapists on a web-based platform instead of the conventional paper-based therapy sessions for their cognitive and speech rehabilitation needs.
More detail
The population group will be adult patients admitted to critical care unit and stroke unit and diagnosed to have speech and cognitive impairment. The intervention is to provide therapy prescribed by therapist through Cognishine, a web-based platform instead of paper-based therapy session. The primary objective is to assess feasibility of using the Cognishine web-based platform in a large NHS Trust in acute care setting measured by number of completed therapy sessions, per patient days.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Patients with cognitive impairment and/or speech impairment being treated at the LUHFT Intensive Care Units and the...
- ✓Need for Cognitive and/or speech and Language rehabilitation
Who cannot take part
- ✗Inability to obtain consent
- ✗Refusal to take part in the study
- ✗Failure to engage with the Cognishine platform
- ✗Inability to operate a mobile device/ tablet with support
- ✗Unavailability of study therapist to provide training of patients
See the full criteria
Where Is This Study? (1 UK site)
Liverpool University Hospitals NHS Foundation Trust
Liverpool l7 8xp, United Kingdom
How to Get in Touch
Vinoth Sankar
Sponsor contactCONTACT